Using qualitative and quantitative strategies to evaluate knowledge and perceptions about sickle cell disease and sickle cell trait

Journal of the National Medical Association

Volumn 98, Issue 5, 2006, Pages 704-710

  Treadwell, Marsha J ^a,b   McClough, Lakenya ^a,b   Vichinsky, Elliott ^a,b  

^a Children's Hospital and Research Center at Oakland ^*

^b CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

African Americans; Health promotion; Sickle cell disease

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CLINICAL ARTICLE; EVALUATION; FEMALE; GENETIC SCREENING; HEALTH PROMOTION; HEALTH STATUS; HEALTH SURVEY; HUMAN; KNOWLEDGE; MALE; PERCEPTION; PRIORITY JOURNAL; PUBLIC HEALTH; QUANTITATIVE ANALYSIS; SICKLE CELL ANEMIA; SICKLE CELL TRAIT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ANEMIA, SICKLE CELL; ATTITUDE OF HEALTH PERSONNEL; CALIFORNIA; CATCHMENT AREA (HEALTH); CLINICAL COMPETENCE; DATA COLLECTION; FEMALE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HOSPITALS, COMMUNITY; HUMANS; INTERVIEWS; MALE; RESIDENCE CHARACTERISTICS; SICKLE CELL TRAIT;

EID: 33646501444     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. The management of sickle cell disease (4th ed). Washington, DC: National Institutes of Health, National Heart, Lung and Blood Institute, 2002. U.S. Dept. of Health and Human Services Publication, NIH 02-2117.
2. Hoppe C, Styles L, Vichinsky E. The natural history of sickle cell disease. Curr Opin Pediatr. 1998;10:49-52.
3. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325:11-16.
4. Walters MC. Bone marrow transplantation for sickle cell disease: where do we go from here? J Pediatr Hematol Oncol. 1999;21:467-474.
5. Gupta AK, Kirchner KA, Nicholson R. Effects of alpha thalassemia and sickle polymerization tendency on the urine concentrating defect of individuals with sickle cell trait. J Clin Invest. 1991;88:1963-1968.
6. Sears DA. Sickle cell trait. Tn: Embury SH, Hebbel RP, Mohandas N, et al. Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY: Raven Press, 1994:383-393.
7. Voge VM, Rosado NR, Contiguglia JJ. Sickle cell anemia trait in the military aircrew population: a report from the Military Aviation Safety Subcommittee of the Aviation Safety Committee, AsMA. Aviat Space Environ Med. 1991;62:1099-1102.
8. Lane PA, Githens JH. Splenic syndrome at mountain altitude in sickle cell trait. Its occurrence in non Black persons. JAMA. 1985;253:2251-2254.
9. Kark JA, Posey DM, Schumacher HR, et al. Sickle cell trait as a risk factor for sudden death in physical training. N Engl J Med. 1987;317:781-788.
10. Weinstein GW. Managing hyphema in Black patients. Ophthalmol Surg. 1979;10:11.
11. Ajayi AA, Kolawole BA. Sickle cell trait and gender influence type 2 diabetic complications in African patients. Eur J Intern Med. 2004;15:312-315.
12. Pass KA, Lane PA, Fernhoff PM, et al. US newborn screening system guidelines II: follow-up of children, diagnosis, management, and evaluation. Statement of the Council of Regional Networks for Genetic Services (CORN). J Pediatr. 2000;137:51-346.
13. Olivers, Dezateux C, Kavanagh J, et al. Disclosing to parents newborn carrier status identified by routine blood spot screening. Cochrane Database Syst Rev. 2004;18:CD003859.
14. Boyd JH, Watkins AR, Price CL, et al. Inadequate community knowledge about sickle cell disease among African American women. J Natl Med Assoc. 2005;97:62-67.
15. Wright SW, Zeldin MH, Wrenn K, et al. Screening for sickle cell trait in the emergency department. J Gen Intern Med. 1994;9:421-424.
16. Rowley PT, Loader S, Sutera CJ, et al. Prenatal screening for hemoglobinopathies. III. Applicability of the health belief model. Am J Hum Genet. 1991;48:452-459.
17. Midence K, Graham V, Acheampong C, et al. Increasing awareness for higher quality care: measuring knowledge of sickle cell disease in adult patients. Professional Nurse. 1994;Jan:255-258.
18. Glanz K, Yang H. Communicating about risk of infectious diseases. JAMA. 1996;275:253-256.
19. Roberts L. One worked: the other didn't. Science. 1990;247:18.
20. Severo R. Genetic screening at Du Pont: Blacks only need apply. Nation. 1980;23:243-245.
21. Markel H. The stigma of disease: implications of genetic screening. Am J Med. 1992;93:209-215.
22. Cantor AB, Miller MC III, Larisey L, et al. A study of media effectiveness for sickle cell anemia education in a rural community. J Natl Med Assoc. 1979;71:1055-1057.
23. Barbour RS, Kitzinger J. (1999). Developing focus group research: Politics, theory, and practice. London, England: Sage.
24. Calderon JL, Baker RS, Wolf KE. Focus groups: a qualitative method complementing quantitative research for studying culturally diverse groups. Educ Health. 2000;13:91-95.
25. Neuendorf KA. The content analysis guidebook. Thousand Oaks, CA: Sage, 2001.
26. SPSS, Inc. SPSS® Base 12.0 User's Guide. Chicago, IL: SPSS Inc., 2003.
27. Williams PB. HIV/AIDS case profile of African Americans: guidelines for ethnic-specific health promotion, education and risk reduction activities for African Americans. Fam Community Health. 2003;26:289-306.
28. James G. A seven-year follow-up comparing attendees and non attendees at a statewide school employee wellness conference. J School Health. 2001;71:127-131.
29. Moore SJ. The role of advance practice nurses in community settings. Nurs Econ. 2002;20:102-108.
30. Schwarzer R, Leppin A. Social support and health: a meta-analysis. Psychology and Health. 1989;3:1-15.
31. Hoyo C, Reid L, Hatch JK, et al. Program prioritization to control chronic diseases in African American faith-based communities. J Natl Med Assoc. 2004;96:524-532.
32. Emmers-Sommer T, Allen M. HIV and AIDS: toward increased awareness and understanding of prevention and education research using meta-analysis. Communication Studies. 2001;52:127-140.
33. Gollust SE, Apse K, Fuller BP, et al. Community involvement in developing policies for genetic testing: assessing the interests and experience of individuals affected by genetic conditions. Am J Public Health. 2005;95:35-41.
34. Whitten CF, Whitten-Shurney W. Sickle cell. Clin Perinatal. 2001;28:435-438.
35. Nelson RM, Botkjin JR, Kodish ED, et al. Committee on Bioethics. Ethical issues with genetic testing in pediatrics. Pediatrics. 2001;107:1451-1455.